Table 4 |
||||
|
Comparison of Selected CSF Biomarker Median Ratios between the three Study Groups |
||||
|
PRO-INFLAMMATORY OR ANGIOSTATIC vs. ANTI-INFLAMMATORY OR ANGIOGENIC BIOMARKER MEDIAN RATIO |
CM |
SMA |
NM |
OVERALL P VALUE |
|
|
||||
|
TNF-α : IL-10 |
3.33 × 10-2 |
7.51 × 10-2 |
2.04 × 10-1 |
NSS |
|
TNF-α : IL-8 |
7.76 × 10-2 |
7.52 × 10-1 |
6.67 × 10-1 |
NSS |
|
TNF-α : PDGFbb |
5.05 × 10-2 |
7.56 × 10-2 |
1.53 × 10-2 |
NSS |
|
IP-10 : IL-10 |
10.28 |
2.07 |
3.14 |
NSS |
|
IP-10 : IL-8 |
23.08 |
20.12 |
10.29 |
NSS |
|
IP-10 : PDGFbb |
15.35 |
2.28 |
2.32 × 10-2 |
0.003 |
|
|
||||
|
Median ratios of CSF levels of pro-inflammatory/angiostatic versus anti-inflammatory/angiogenic biomarkers were compared between the three disease groups; P < 0.05 considered statistically significant; NSS, not statistically significant. |
||||
|
Armah et al. Malaria Journal 2007 6:147 doi:10.1186/1475-2875-6-147 |
||||